European Organisation For Research And Treatment Of Cancer - Eortc

This study tested a personalized approach for teenagers and young adults with a rare brain tumor called medulloblastoma. It aimed to see if giving a targeted drug (sonidegib) along with lower radiation doses could improve outcomes and reduce side effects. The trial was stopped ea…

This study tested whether the drug nintedanib could help people with a rare lung cancer called malignant pleural mesothelioma. Patients who had stable disease or improvement after initial chemotherapy were given either nintedanib or a placebo to see if it delayed cancer growth. T…